(CIDRAP News) – The tuberculosis toll in Europe continued a slow overall decline in 2010, but the treatment success rate for the disease is slipping as drug-resistant strains of TB grow more common, according to a report released today by the European Union (EU) and the World Health Organization (WHO).
(CIDRAP News) – Infectious-disease specialty groups are teaming up to call for increased use of antimicrobial stewardship programs, saying such efforts can help preserve the effectiveness of anti-infective drugs while reducing medical costs.
(CIDRAP News) – In a new twist in the ongoing controversy over publication of two studies involving H5N1 viruses with increased transmissibility, there are indications that the Dutch government may consider using export regulations to prevent full publication of the study by Ron Fouchier, PhD, and colleagues.
(CIDRAP News) – Flu activity in the United States continued its late-season rise last week, with more respiratory specimens testing positive and more states reporting widespread activity, but flu-like illness stayed relatively low overall, the US Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the first quadrivalent influenza vaccine, an inhaled live attenuated influenza vaccine developed by MedImmune and modeled after its FluMist product.
The vaccine includes a second influenza B strain, which is designed to broaden protection against circulating strains. MedImmune plans to have the quadrivalent vaccine ready for the 2013-14 flu season.